anti-CD3/anti-tumor antigen bispecific T-cell engager antibody program Probody/Pb-TCB (CytomX/Astellas)

N/A

Report date: 2026/03/19 16:58:19

Base Information

Drug Nameanti-CD3/anti-tumor antigen bispecific T-cell engager antibody program Probody/Pb-TCB (CytomX/Astellas)
Drug Alias NameCD3-TCB Probody/Pb-TCB (CytomX/Astellas)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A